The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial-Reference-Cited by-同舟云学术

The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial

Published:2014-03-17 Issue:27 Volume:35 Page:1792-1800
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Ray Kausik K.¹,Ditmarsch Marc²,Kallend David²,Niesor Eric J.²,Suchankova Gabriela²,Upmanyu Ruchi³,Anzures-Cabrera Judith³,Lehnert Valerie²,Pauly-Evers Meike²,Holme Ingar⁴,Št́ásek Josef⁵,van Hessen Maarten W. J.⁶,Jones Peter⁷,

Affiliation:

1. Cardiovascular Sciences Research Centre, St George's University of London, Cranmer Terrace, London, SW17 OREUK

2. F. Hoffmann-La Roche Ltd, Basel, Switzerland

3. Roche Products Ltd, Welwyn Garden City, UK

4. Department of Endocrinology, Obesity and Preventive Medicine, Oslo University Hospital, Ulleval, Oslo, Norway

5. Charles University Faculty Hospital, Hradec Králové, Czech Republic

6. Groene Hart Ziekenhuis, Gouda, The Netherlands

7. Baylor College of Medicine, Houston, TX, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine